Hall, Lisa http://orcid.org/0000-0002-9309-9315
White, Nicole M.
Allen, Michelle
Farrington, Alison
Mitchell, Brett G.
Page, Katie
Halton, Kate
Riley, Thomas V.
Gericke, Christian A.
Graves, Nicholas
Gardner, Anne
Funding for this research was provided by:
National Health and Medical Research Council (GNT1076006)
Article History
Received: 20 October 2019
Accepted: 6 February 2020
First Online: 18 February 2020
Ethics approval and consent to participate
: The REACH study was registered with the Australian and New Zealand Clinical Trial Registry on 09/04/2015 - ACTRN12615000325505. Overarching institutional approval was obtained from the Uniting Care Health Human Research Ethics Committee (1413) and the Queensland University of Technology Human Research Ethics Committee (1400000828). Local ethics and site-specific governance approvals were obtained for all participating hospitals.
: Not applicable
: All authors have completed the ICMJE uniform disclosure form at ExternalRef removed and declare support from the NHMRC, Kimberly-Clark Professional, Ecolab Pty Ltd. and Whiteley Corporation for the submitted work. TVR reports research grants and non-financial support from GAMA Health, Roche Molecular Systems, Summit Pharmaceuticals, Merck, Sanofi and Cepheid.